Literature DB >> 35478228

Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips.

Nathaniel Huebsch1,2, Berenice Charrez1, Gabriel Neiman1, Brian Siemons1, Steven C Boggess3, Samuel Wall4, Verena Charwat1, Karoline H Jæger4, David Cleres1, Åshild Telle4, Felipe T Lee-Montiel1, Nicholas C Jeffreys1, Nikhil Deveshwar1, Andrew G Edwards5, Jonathan Serrano6, Matija Snuderl6, Andreas Stahl7, Aslak Tveito4, Evan W Miller3,8,9, Kevin E Healy10,11.   

Abstract

The immature physiology of cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs) limits their utility for drug screening and disease modelling. Here we show that suitable combinations of mechanical stimuli and metabolic cues can enhance the maturation of hiPSC-derived cardiomyocytes, and that the maturation-inducing cues have phenotype-dependent effects on the cells' action-potential morphology and calcium handling. By using microfluidic chips that enhanced the alignment and extracellular-matrix production of cardiac microtissues derived from genetically distinct sources of hiPSC-derived cardiomyocytes, we identified fatty-acid-enriched maturation media that improved the cells' mitochondrial structure and calcium handling, and observed divergent cell-source-dependent effects on action-potential duration (APD). Specifically, in the presence of maturation media, tissues with abnormally prolonged APDs exhibited shorter APDs, and tissues with aberrantly short APDs displayed prolonged APDs. Regardless of cell source, tissue maturation reduced variabilities in spontaneous beat rate and in APD, and led to converging cell phenotypes (with APDs within the 300-450 ms range characteristic of human left ventricular cardiomyocytes) that improved the modelling of the effects of pro-arrhythmic drugs on cardiac tissue.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35478228     DOI: 10.1038/s41551-022-00884-4

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  65 in total

Review 1.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes.

Authors:  Kavitha T Kuppusamy; Daniel C Jones; Henrik Sperber; Anup Madan; Karin A Fischer; Marita L Rodriguez; Lil Pabon; Wei-Zhong Zhu; Nathaniel L Tulloch; Xiulan Yang; Nathan J Sniadecki; Michael A Laflamme; Walter L Ruzzo; Charles E Murry; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

3.  Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation.

Authors:  Amandine F G Godier-Furnémont; Malte Tiburcy; Eva Wagner; Matthias Dewenter; Simon Lämmle; Ali El-Armouche; Stephan E Lehnart; Gordana Vunjak-Novakovic; Wolfram-Hubertus Zimmermann
Journal:  Biomaterials       Date:  2015-05-15       Impact factor: 12.479

4.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

Authors:  Junyi Ma; Liang Guo; Steve J Fiene; Blake D Anson; James A Thomson; Timothy J Kamp; Kyle L Kolaja; Bradley J Swanson; Craig T January
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

5.  Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.

Authors:  Donghui Zhang; Ilya Y Shadrin; Jason Lam; Hai-Qian Xian; H Ralph Snodgrass; Nenad Bursac
Journal:  Biomaterials       Date:  2013-05-02       Impact factor: 12.479

6.  Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Authors:  Ping Liang; Feng Lan; Andrew S Lee; Tingyu Gong; Veronica Sanchez-Freire; Yongming Wang; Sebastian Diecke; Karim Sallam; Joshua W Knowles; Paul J Wang; Patricia K Nguyen; Donald M Bers; Robert C Robbins; Joseph C Wu
Journal:  Circulation       Date:  2013-03-21       Impact factor: 29.690

7.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.

Authors:  Scott D Lundy; Wei-Zhong Zhu; Michael Regnier; Michael A Laflamme
Journal:  Stem Cells Dev       Date:  2013-04-05       Impact factor: 3.272

8.  Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.

Authors:  M Paci; J Hyttinen; B Rodriguez; S Severi
Journal:  Br J Pharmacol       Date:  2015-10-15       Impact factor: 8.739

9.  Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.

Authors:  Hiroko Iseoka; Shigeru Miyagawa; Satsuki Fukushima; Atsuhiro Saito; Shigeo Masuda; Shin Yajima; Emiko Ito; Nagako Sougawa; Maki Takeda; Akima Harada; Jong-Kook Lee; Yoshiki Sawa
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

10.  HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.

Authors:  John T Hinson; Anant Chopra; Navid Nafissi; William J Polacheck; Craig C Benson; Sandra Swist; Joshua Gorham; Luhan Yang; Sebastian Schafer; Calvin C Sheng; Alireza Haghighi; Jason Homsy; Norbert Hubner; George Church; Stuart A Cook; Wolfgang A Linke; Christopher S Chen; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2015-08-28       Impact factor: 47.728

View more
  5 in total

1.  Robust, Automated Analysis of Electrophysiology in Induced Pluripotent Stem Cell-Derived Micro-Heart Muscle for Drug Toxicity.

Authors:  Kasoorelope Oguntuyo; David Schuftan; Jingxuan Guo; Daniel Simmons; Druv Bhagavan; Jonathan D Moreno; Po Wei Kang; Evan Miller; Jonathan R Silva; Nathaniel Huebsch
Journal:  Tissue Eng Part C Methods       Date:  2022-08-04       Impact factor: 3.273

2.  Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System.

Authors:  Verena Charwat; Bérénice Charrez; Brian A Siemons; Henrik Finsberg; Karoline H Jæger; Andrew G Edwards; Nathaniel Huebsch; Samuel Wall; Evan Miller; Aslak Tveito; Kevin E Healy
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-29

Review 3.  Challenges and opportunities for the next generation of cardiovascular tissue engineering.

Authors:  Sangkyun Cho; Dennis E Discher; Kam W Leong; Gordana Vunjak-Novakovic; Joseph C Wu
Journal:  Nat Methods       Date:  2022-09-05       Impact factor: 47.990

4.  Fusing spheroids to aligned μ-tissues in a heart-on-chip featuring oxygen sensing and electrical pacing capabilities.

Authors:  Oliver Schneider; Alessia Moruzzi; Stefanie Fuchs; Alina Grobel; Henrike S Schulze; Torsten Mayr; Peter Loskill
Journal:  Mater Today Bio       Date:  2022-05-07

5.  Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation.

Authors:  Homa Hamledari; Parisa Asghari; Farah Jayousi; Alejandro Aguirre; Yasaman Maaref; Tiffany Barszczewski; Terri Ser; Edwin Moore; Wyeth Wasserman; Ramon Klein Geltink; Sheila Teves; Glen F Tibbits
Journal:  Front Cardiovasc Med       Date:  2022-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.